Max Parker

Q: What is Max Parker email address?

Email Max Parker at edward.lawrence@juno.com and max.parker@pfizer.com. This email is the most updated Max Parker email found in 2026.

Q: How to contact Max Parker?

To contact Max Parker send an email to edward.lawrence@juno.com or max.parker@pfizer.com. (updated on October 30, 2024)

ASSOCIATE DIRECTOR – ONCOLOGY RESEARCH ALLIANCES at Pfizer | San Diego, California, United States

About Max Parker

Max Parker is a seasoned Senior Principal Scientist specializing in Oncology Alliances and Collaborations at Pfizer, where he plays a pivotal role in advancing the company's oncology research portfolio. With a robust background in in-vitro biology, Max has cultivated a wealth of expertise in target validation and exploratory biology, which has been instrumental in driving innovative drug development initiatives. His resourceful and customer-focused approach enables him to effectively navigate the complexities of both internal organizational structures and external collaborations, including partnerships with international research institutions and Contract Research Organizations (CROs).

In his current role, Max leads efforts to optimize domestic and global collaborations, ensuring that experimental and resource demands are met in a timely and cost-effective manner. His strategic oversight not only enhances the efficiency of research projects but also fosters a culture of collaboration that is essential for success in the competitive landscape of oncology research. Since his promotion from Principal Scientist to Senior Principal Scientist in 2021, Max has taken on greater leadership responsibilities, guiding cross-functional teams to align their objectives with Pfizer's overarching mission to deliver breakthrough therapies.

Max's extensive skill set encompasses biotechnology, drug design, biochemistry, and pharmacology, making him a key player in the drug development process. His ability to integrate scientific knowledge with project and resource management ensures that Pfizer remains at the forefront of oncology research, ultimately contributing to the development of novel therapies that can significantly improve patient outcomes. Through his dedication and expertise, Max Parker exemplifies the innovative spirit that drives Pfizer's commitment to transforming cancer care.

Max Parker Work